Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Blue

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
General Pharmacology|September 11, 1992
Slow off-rate of prazosin accounts for deviations from competitive antagonism in the isolated perfused kidney of ratD R Blue, D E Clarke
British Journal of Pharmacology|October 11, 1992
Evidence for a noradrenergic innervation to alpha 1A-adrenoceptors in rat kidneyD R Blue, R L Vimont, D E Clarke
Trends in Pharmacological Sciences|June 1, 1994
Alpha 1-adrenoceptor classification: sharpening Occam's razorA P Ford, T J Williams, D R Blue, et al.
British Journal of Pharmacology|May 14, 1998
Alpha1L-adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of manM S Kava, D R Blue, R L Vimont, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cellsD R Blue, D A Craig, J T Ransom, et al.
British Journal of Pharmacology|April 27, 1999
Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic miceQ M Zhu, J D Lesnick, J R Jasper, et al.
Annals of the New York Academy of Sciences|July 23, 1999
alpha 2A-adrenoceptors, not I1-imidazoline receptors, mediate the hypotensive effects of rilmenidine and moxonidine in conscious mice. In vivo and in vitro studiesQ M Zhu, J D Lesnick, J R Jasper, et al.
International Journal of Impotence Research|August 30, 2001
Evaluation of oral ro70-0004/003, an alpha1A-adrenoceptor antagonist, in the treatment of male erectile dysfunctionA Choppin, D R Blue, S S Hegde, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenololD R Blue, R A Bond, N Adham, et al.
BJU International|December 18, 2003
Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinenceD R Blue, D V Daniels, J R Gever, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
General Pharmacology|September 11, 1992
Slow off-rate of prazosin accounts for deviations from competitive antagonism in the isolated perfused kidney of ratD R Blue, D E Clarke
British Journal of Pharmacology|October 11, 1992
Evidence for a noradrenergic innervation to alpha 1A-adrenoceptors in rat kidneyD R Blue, R L Vimont, D E Clarke
Trends in Pharmacological Sciences|June 1, 1994
Alpha 1-adrenoceptor classification: sharpening Occam's razorA P Ford, T J Williams, D R Blue, et al.
British Journal of Pharmacology|May 14, 1998
Alpha1L-adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of manM S Kava, D R Blue, R L Vimont, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cellsD R Blue, D A Craig, J T Ransom, et al.
British Journal of Pharmacology|April 27, 1999
Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic miceQ M Zhu, J D Lesnick, J R Jasper, et al.
Annals of the New York Academy of Sciences|July 23, 1999
alpha 2A-adrenoceptors, not I1-imidazoline receptors, mediate the hypotensive effects of rilmenidine and moxonidine in conscious mice. In vivo and in vitro studiesQ M Zhu, J D Lesnick, J R Jasper, et al.
International Journal of Impotence Research|August 30, 2001
Evaluation of oral ro70-0004/003, an alpha1A-adrenoceptor antagonist, in the treatment of male erectile dysfunctionA Choppin, D R Blue, S S Hegde, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenololD R Blue, R A Bond, N Adham, et al.
BJU International|December 18, 2003
Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinenceD R Blue, D V Daniels, J R Gever, et al.
Pageof 2